LENZ Therapeutics, Inc.LENZNASDAQ
Loading
SG&A Expenses Over TimeExpanding
Percentile Rank100
3Y CAGR+175.4%
5Y CAGR+84.5%
Studio
Year-over-Year Change

Selling, general, and administrative expenses

3Y CAGR
+175.4%/yr
Annual compound
5Y CAGR
+84.5%/yr
Recent acceleration
Percentile
P100
Near historical high
vs 5Y Ago
21.4x
Strong expansion
Streak
3 yr
Consecutive growthExpanding
PeriodValueYoY Change
TTM$91.01M+216.6%
2024$28.75M+122.4%
2023$12.93M+196.6%
2022$4.36M-80.0%
2021$21.78M+411.7%
2020$4.26M+14575.9%
2019$29000.00-